We have located links that may give you full text access.
Racial and Ethnic Differences in Long-Term Adverse Radiotherapy Effects among Breast Cancer Survivors.
International Journal of Radiation Oncology, Biology, Physics 2023 September 25
PURPOSE: Breast and skin changes are an underrecognized side effect of radiotherapy for breast cancer, which may have long-term implications for quality of life (QOL). Racial and ethnic disparities in breast cancer outcomes including long-term QOL differences following breast radiotherapy are poorly understood.
METHODS AND MATERIALS: We conducted a cross-sectional survey study of patients from the XYZ Cancer Registry diagnosed with stage 0-II breast cancer from 2009-2014 and treated with lumpectomy and radiotherapy; 2,770 patients were sampled and 631 responded (23%). The BREAST-Q Adverse Effects of Radiation (AER) overall score and subindices measured the impact of radiotherapy on breast tissue. Multivariable logistic regression evaluated associations of demographic and treatment characteristics with outcomes.
RESULTS: The median age was 57 years (IQR 48-65), median time from diagnosis to survey response 9 years (IQR 7-10), and the cohort included 62 (9.8%) Asian American or Pacific Islander, 11 (1.7%) American Indian or Alaskan Native (AIAN), 161 (25.5%) Black, 144 (22.8%) Hispanic, and 253 (40.1%) White patients. Mean BREAST-Q AER score was worse for AIAN patients (-22.2, 95% CI -39.9 to -4.6, p=0.01), Black patients (-10.8, 95% CI -16.1 to -5.5, p<0.001), and Hispanic patients (-7.8, 95% CI -13.0 to -2.5, p=0.004) compared to White patients, age <50 compared to ≥65 (effect size -8.6, 95% CI -14.0 to -3.2, p=0.002), less than a college education (-5.8, 95% CI -10.0 to -1.6, p=0.01), bra cup size of D/E versus A/B (-5.3, 95% CI -9.9 to -0.65, p=0.03), and current smokers (-11.3, 95% CI -18.3 to -4.2, p=0.002). AIAN, Black, and Hispanic patients reported worse changes in skin pigmentation, telangiectasias, dryness, soreness, and/or irritation compared to White patients.
CONCLUSIONS: AIAN, Black, and Hispanic patients reported substantially worse long-term breast and skin QOL outcomes after radiotherapy. Additional work is needed to understand these differences and how to alleviate them.
METHODS AND MATERIALS: We conducted a cross-sectional survey study of patients from the XYZ Cancer Registry diagnosed with stage 0-II breast cancer from 2009-2014 and treated with lumpectomy and radiotherapy; 2,770 patients were sampled and 631 responded (23%). The BREAST-Q Adverse Effects of Radiation (AER) overall score and subindices measured the impact of radiotherapy on breast tissue. Multivariable logistic regression evaluated associations of demographic and treatment characteristics with outcomes.
RESULTS: The median age was 57 years (IQR 48-65), median time from diagnosis to survey response 9 years (IQR 7-10), and the cohort included 62 (9.8%) Asian American or Pacific Islander, 11 (1.7%) American Indian or Alaskan Native (AIAN), 161 (25.5%) Black, 144 (22.8%) Hispanic, and 253 (40.1%) White patients. Mean BREAST-Q AER score was worse for AIAN patients (-22.2, 95% CI -39.9 to -4.6, p=0.01), Black patients (-10.8, 95% CI -16.1 to -5.5, p<0.001), and Hispanic patients (-7.8, 95% CI -13.0 to -2.5, p=0.004) compared to White patients, age <50 compared to ≥65 (effect size -8.6, 95% CI -14.0 to -3.2, p=0.002), less than a college education (-5.8, 95% CI -10.0 to -1.6, p=0.01), bra cup size of D/E versus A/B (-5.3, 95% CI -9.9 to -0.65, p=0.03), and current smokers (-11.3, 95% CI -18.3 to -4.2, p=0.002). AIAN, Black, and Hispanic patients reported worse changes in skin pigmentation, telangiectasias, dryness, soreness, and/or irritation compared to White patients.
CONCLUSIONS: AIAN, Black, and Hispanic patients reported substantially worse long-term breast and skin QOL outcomes after radiotherapy. Additional work is needed to understand these differences and how to alleviate them.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Ventilator Waveforms May Give Clues to Expiratory Muscle Activity.American Journal of Respiratory and Critical Care Medicine 2024 April 25
Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use.Pharmaceuticals 2024 March 27
Systemic lupus erythematosus.Lancet 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app